BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23640455)

  • 1. A caspase-3 'death-switch' in colorectal cancer cells for induced and synchronous tumor apoptosis in vitro and in vivo facilitates the development of minimally invasive cell death biomarkers.
    Simpson KL; Cawthorne C; Zhou C; Hodgkinson CL; Walker MJ; Trapani F; Kadirvel M; Brown G; Dawson MJ; MacFarlane M; Williams KJ; Whetton AD; Dive C
    Cell Death Dis; 2013 May; 4(5):e613. PubMed ID: 23640455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating biomarkers of cell death after treatment with the BH-3 mimetic ABT-737 in a preclinical model of small-cell lung cancer.
    Micha D; Cummings J; Shoemaker A; Elmore S; Foster K; Greaves M; Ward T; Rosenberg S; Dive C; Simpson K
    Clin Cancer Res; 2008 Nov; 14(22):7304-10. PubMed ID: 19010845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained tumour eradication after induced caspase-3 activation and synchronous tumour apoptosis requires an intact host immune response.
    Melis MH; Simpson KL; Dovedi SJ; Welman A; MacFarlane M; Dive C; Honeychurch J; Illidge TM
    Cell Death Differ; 2013 May; 20(5):765-73. PubMed ID: 23412345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design of caspase-responsive smart molecular probe for positron emission tomography imaging of drug-induced apoptosis.
    Qiu L; Wang W; Li K; Peng Y; Lv G; Liu Q; Gao F; Seimbille Y; Xie M; Lin J
    Theranostics; 2019; 9(23):6962-6975. PubMed ID: 31660080
    [No Abstract]   [Full Text] [Related]  

  • 5. Specific demonstration of drug-induced tumour cell apoptosis in human xenografts models using a plasma biomarker.
    Olofsson MH; Cummings J; Fayad W; Brnjic S; Herrmann R; Berndtsson M; Hodgkinson C; Dean E; Odedra R; Wilkinson RW; Mundt KE; Busk M; Dive C; Linder S
    Cancer Biomark; 2009; 5(3):117-25. PubMed ID: 19407366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical Kinetic Analysis of the Caspase-3/7 PET Tracer 18F-C-SNAT: Quantifying the Changes in Blood Flow and Tumor Retention After Chemotherapy.
    Palner M; Shen B; Jeon J; Lin J; Chin FT; Rao J
    J Nucl Med; 2015 Sep; 56(9):1415-21. PubMed ID: 26045308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A peptide-based positron emission tomography probe for in vivo detection of caspase activity in apoptotic cells.
    Hight MR; Cheung YY; Nickels ML; Dawson ES; Zhao P; Saleh S; Buck JR; Tang D; Washington MK; Coffey RJ; Manning HC
    Clin Cancer Res; 2014 Apr; 20(8):2126-35. PubMed ID: 24573549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspase-3 probes for PET imaging of apoptotic tumor response to anticancer therapy.
    Elvas F; Vanden Berghe T; Adriaenssens Y; Vandenabeele P; Augustyns K; Staelens S; Stroobants S; Van der Veken P; Wyffels L
    Org Biomol Chem; 2019 May; 17(19):4801-4824. PubMed ID: 31033991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical assessment of carboplatin treatment efficacy in lung cancer by 18F-ICMT-11-positron emission tomography.
    Witney TH; Fortt R; Aboagye EO
    PLoS One; 2014; 9(3):e91694. PubMed ID: 24618809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of [
    Rapic S; Vangestel C; Elvas F; Verhaeghe J; den Wyngaert TV; Wyffels L; Pauwels P; Staelens S; Stroobants S
    Mol Imaging Biol; 2017 Aug; 19(4):560-569. PubMed ID: 28050749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining [11C]-AnxA5 PET imaging with serum biomarkers for improved detection in live mice of modest cell death in human solid tumor xenografts.
    Cheng Q; Lu L; Grafström J; Olofsson MH; Thorell JO; Samén E; Johansson K; Ahlzén HS; Stone-Elander S; Linder S; Arnér ES;
    PLoS One; 2012; 7(8):e42151. PubMed ID: 22870292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal and spatial evolution of therapy-induced tumor apoptosis detected by caspase-3-selective molecular imaging.
    Nguyen QD; Lavdas I; Gubbins J; Smith G; Fortt R; Carroll LS; Graham MA; Aboagye EO
    Clin Cancer Res; 2013 Jul; 19(14):3914-24. PubMed ID: 23729364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [
    Chen M; Chen Z; Castillo JB; Cui L; Zhou K; Shen B; Xie J; Chin FT; Rao J
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3386-3399. PubMed ID: 33712870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [18F]FLT is superior to [18F]FDG for predicting early response to antiproliferative treatment in high-grade lymphoma in a dose-dependent manner.
    Graf N; Herrmann K; Numberger B; Zwisler D; Aichler M; Feuchtinger A; Schuster T; Wester HJ; Senekowitsch-Schmidtke R; Peschel C; Schwaiger M; Keller U; Dechow T; Buck AK
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):34-43. PubMed ID: 23053327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-3/7 specific [18F]-labeled isatin sulfonamide.
    Nguyen QD; Smith G; Glaser M; Perumal M; Arstad E; Aboagye EO
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16375-80. PubMed ID: 19805307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-triggered nanoaggregation probe.
    Shen B; Jeon J; Palner M; Ye D; Shuhendler A; Chin FT; Rao J
    Angew Chem Int Ed Engl; 2013 Sep; 52(40):10511-4. PubMed ID: 23881906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of apoptosis imaging biomarkers in a genetic model of cell death.
    Vassileva V; Stribbling SM; Barnes C; Carroll L; Braga M; Abrahams J; Heinzmann K; Haegeman C; MacFarlane M; Simpson KL; Dive C; Honeychurch J; Illidge TM; Aboagye EO
    EJNMMI Res; 2019 Feb; 9(1):18. PubMed ID: 30783791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular imaging of therapeutic response to epidermal growth factor receptor blockade in colorectal cancer.
    Manning HC; Merchant NB; Foutch AC; Virostko JM; Wyatt SK; Shah C; McKinley ET; Xie J; Mutic NJ; Washington MK; LaFleur B; Tantawy MN; Peterson TE; Ansari MS; Baldwin RM; Rothenberg ML; Bornhop DJ; Gore JC; Coffey RJ
    Clin Cancer Res; 2008 Nov; 14(22):7413-22. PubMed ID: 19010858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging caspase-3 activation as a marker of apoptosis-targeted treatment response in cancer.
    Chen DL; Engle JT; Griffin EA; Miller JP; Chu W; Zhou D; Mach RH
    Mol Imaging Biol; 2015 Jun; 17(3):384-93. PubMed ID: 25344147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiopharmacological evaluation of a caspase-3 responsive probe with optimized pharmacokinetics for PET imaging of tumor apoptosis.
    Wang S; Gao D; Li K; Ye S; Liu Q; Peng Y; Lv G; Qiu L; Lin J
    Org Biomol Chem; 2020 May; 18(18):3512-3521. PubMed ID: 32334424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.